{"id":"ctx-4430","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4297604","moleculeType":"Small molecule","molecularWeight":"481.55"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"NOX2 is a key component of the respiratory burst in phagocytes, and its inhibition has been shown to reduce inflammation and oxidative stress. CTX-4430 works by selectively inhibiting the activity of NOX2, which may help to mitigate the symptoms of certain inflammatory diseases.","oneSentence":"CTX-4430 is a small molecule inhibitor of the NADPH oxidase 2 (NOX2) enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:46.462Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic Granulomatous Disease"}]},"trialDetails":[{"nctId":"NCT05203835","phase":"PHASE2","title":"Trial of Acebilustat for the Treatment of Upper Arm Lymphedema","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2022-07-27","conditions":"Lymphedema of Upper Arm","enrollment":40},{"nctId":"NCT04662086","phase":"PHASE2","title":"COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-04-23","conditions":"Covid19","enrollment":122},{"nctId":"NCT04662060","phase":"PHASE2","title":"COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-04-23","conditions":"Covid19","enrollment":120},{"nctId":"NCT02443688","phase":"PHASE2","title":"EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2015-10-30","conditions":"Cystic Fibrosis","enrollment":200},{"nctId":"NCT03964558","phase":"PHASE1","title":"Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2019-04-01","conditions":"Heathy Volunteers","enrollment":6},{"nctId":"NCT02385760","phase":"PHASE2","title":"CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":124},{"nctId":"NCT01944735","phase":"PHASE1","title":"Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2013-09","conditions":"Cystic Fibrosis","enrollment":17},{"nctId":"NCT02233244","phase":"PHASE1","title":"Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2014-09","conditions":"Healthy","enrollment":20},{"nctId":"NCT01748838","phase":"PHASE1","title":"Phase 1 Study Assessing the Safety and Tolerability of CTX-4430","status":"COMPLETED","sponsor":"Celtaxsys, Inc.","startDate":"2012-12","conditions":"Pulmonary Inflammation","enrollment":96}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CTX-4430","genericName":"CTX-4430","companyName":"Celtaxsys, Inc.","companyId":"celtaxsys-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CTX-4430 is a small molecule inhibitor of the NADPH oxidase 2 (NOX2) enzyme. Used for Chronic Granulomatous Disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}